Abstract

Pelvic organ prolapse (POP) affects 30%–70% of women’s health to varying degrees, and numerous risk factors have been confirmed. For patients with moderate to severe POP, surgical intervention is the primary solution. The application of mesh materials, especially tissue-engineered materials, is more desirable for surgical outcomes. Compared to those for traditional surgery, the recurrence and reoperation rates for mesh implantation are low. The continuous development and improvement of tissue engineering technology and various related procedures offer good prospects. However, there is still no consensus on the criteria for POP treatment. Therefore, in this review, we describe the effects of different types of mesh materials and several related representative implantation procedures, explore the potential concerns and future remedies, and provide information for optimizing mesh implantation and formulating POP clinical protocols.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call